Chemical Component Summary

NameUBIQUINONE-10
Identifiers2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methyl-cyclohexa-2,5-diene-1,4-dione
FormulaC59 H90 O4
Molecular Weight863.34
TypeNON-POLYMER
Isomeric SMILESCOC1=C(OC)C(=O)C(=C(C)C1=O)C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C
InChIInChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+
InChIKeyACTIUHUUMQJHFO-UPTCCGCDSA-N

Chemical Details

Formal Charge0
Atom Count153
Chiral Atom Count0
Bond Count153
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB09270 
NameUbidecarenone
Groups
  • approved
  • investigational
  • nutraceutical
DescriptionUbidecarenone, also called coenzyme Q10, is a 1,4-benzoquinone. From his name (Q10), the Q refers to the constitutive quinone group, and 10 is related to the number of isoprenyl subunits in its tail.[A7874] It is a powerful antioxidant, a lipid-soluble and essential cofactor in mitochondrial oxidative phosphorylation.[A31413] The ubidecarenone is the coenzyme destined for mitochondrial enzyme complexes involved in oxidative phosphorylation in the production of ATP. It is fundamental for cells that have a high metabolic demand.[L1062] Ubidecarenone is sold as a dietary supplement and is not FDA approved as a drug thus, it is not meant to treat, cure or prevent any disease. FDA does not approve this dietary supplements before sold nor regulate the manufacturing process.[L1063]
Synonyms
  • Coenzyme Q-10
  • Ubidecarenone
  • Coenzyme q10, (2z)-
  • Coenzyme Q10
Brand Names
  • Fibrik
  • Folika-V
  • Coenzyme Q10 Ubiquinone 60mg - Cap
  • Coenzyme Q10 50mg
  • Coenzyme Q10 Isotonix Vitamin and Mineral Supplement
IndicationThe diet supplements containing ubidecarenone are indicated, as stated in the product label, to assist individuals with cardiovascular complaints including congestive heart failure and systolic hypertension. In the product, ubidecarenone is used to increase the cardiac input as well as for the prevention of several other diseases like Parkinson, fibromyalgia, migraine, periodontal disease and diabetes, based on preclinical studies.[L1064] It is important to highlight that these products are not FDA approved and it is recommended to use under discretion.
Categories
  • Agents Causing Muscle Toxicity
  • Benzoquinones
  • Cardiac Therapy
  • Coenzymes
  • Diet, Food, and Nutrition
ATC-CodeC01EB09
CAS number303-98-0

Drug Targets

NameTarget SequencePharmacological ActionActions
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrialMAAPCLLRQGRAGALKTMLQEAQVFRGLASTVSLSAESGKSEKGQPQNSK...unknowncofactor
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrialMSGVRGLSRLLSARRLALAKAWPTVLQTGTRGFHFTVDGNKRASAKVSDS...unknowncofactor
3-hydroxy-3-methylglutaryl-coenzyme A reductaseMLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYEC...unknownsubstrate
Low-density lipoprotein receptorMGPWGWKLRWTVALLLAAAGTAVGDRCERNEFQCQDGKCISYKWVCDGSA...unknownsubstrate
Very low-density lipoprotein receptorMGTSALWALWLLLALCWAPRESGATGTGRKAKCEPSQFQCTNGRCITLLW...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682